These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2807127

  • 1. [Anemia in patients on continuous ambulatory peritoneal dialysis (CAPD)].
    Tokuda Y, Itou H, Uchida Y, Azuma K, Ohtsuka H, Uomizu K, Yamashita W, Harada R, Nakashima A, Morita T.
    Fukuoka Igaku Zasshi; 1989 Jul; 80(7):379-84. PubMed ID: 2807127
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity.
    Bajo MA, Selgas R, Miranda B, Fernandez-Zamorano A, Borrego F, Romero JR, Caparros G, Riñon C, Sanchez Sicilia L.
    Adv Perit Dial; 1991 Jul; 7():296-300. PubMed ID: 1680450
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 Jul; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.
    Grzegorzewska AE, Mariak I.
    Adv Perit Dial; 2001 Jul; 17():5-9. PubMed ID: 11510296
    [Abstract] [Full Text] [Related]

  • 11. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 1999 Jul; 15():60-4. PubMed ID: 10682073
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
    Zelichowski G, Lubas A, Sienkiewicz M, Janusz E, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis].
    García Martín F, Carrascosa Vallejo T, Martín Escobar E, Val Begueria J, Martín Hernández R, de Arriba G, Teno C, Salvatierra J.
    Rev Clin Esp; 1990 May; 186(9):419-22. PubMed ID: 2247677
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.